| 000 | 01590 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518092125.0 | ||
| 264 | 0 | _c20210125 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1462-0332 | ||
| 024 | 7 |
_a10.1093/rheumatology/keaa079 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrusche, Martin | |
| 245 | 0 | 0 |
_aTocilizumab treatment for polyarteritis nodosa. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cOct 2020 |
||
| 300 |
_ae63-e65 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAftercare |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMusculoskeletal Diseases _xetiology |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xetiology |
| 650 | 0 | 4 |
_aPolyarteritis Nodosa _xcomplications |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRuffer, Nikolas | |
| 700 | 1 | _aSchneider, Udo | |
| 700 | 1 | _aMeyer, Marco | |
| 700 | 1 | _aBurmester, Gerd | |
| 700 | 1 | _aKötter, Ina | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 59 _gno. 10 _gp. e63-e65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/keaa079 _zAvailable from publisher's website |
| 999 |
_c30751131 _d30751131 |
||